VenoStent Raises $20M for Dialysis Solution, Secures $3.6M NIH Grant for U.S. Dialysis Therapeutic Clinical Trial
What You Should Know:
– VenoStent, Inc., a medical device company pioneering a new approach to improve dialysis patient outcomes, announced the successful completion of its Series A funding round. The round closed at $20M,…
Continue Reading